Whitney Cowell1, Elena Colicino2, Talia Askowitz3, Farida Nentin4, Rosalind J Wright2,3. 1. Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA. whitney.cowell@mssm.edu. 2. Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 3. Department of Pediatrics, Kravis Children's Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 4. Department of Obstetrics and Gynecology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abstract
BACKGROUND: Fetal sex is known to modify the course and complications of pregnancy, with recent evidence of sex-differential fetal influences on the maternal immune and endocrine systems. In turn, heightened inflammation and surges in reproductive hormone levels associated with pregnancy and parturition have been linked with the development of perinatal depression. Here, we examined whether there is an association between fetal sex and maternal depression assessed during the prenatal and postnatal periods. METHODS: The study included two multi-ethnic, prospective pregnancy cohorts that enrolled women from prenatal clinics in the Northeastern United States between 2001 and 2018. Maternal depressive symptoms were measured during the prenatal and postnatal periods using the Edinburgh Postpartum Depression Scale (EPDS), and newborn sex was reported by the mother following delivery. We used logistic regression to examine associations between fetal sex and maternal depressive symptoms (EPDS > 10) during the prenatal period only, postnatal period only, or both periods versus no depressive symptoms during either period. We considered both unadjusted models and models adjusted for a core set of sociodemographic and lifestyle variables. RESULTS: In adjusted models using PRISM data (N = 528), women pregnant with a male versus female fetus had significantly greater odds of depressive symptoms during the postnatal period compared to women without depressive symptoms during either period (odds ratio [OR] = 5.24, 95% confidence interval [CI] = 1.93, 14.21). The direction of results was consistent in the ACCESS cohort, although the findings did not reach statistical significance (OR = 2.05, 95% CI = 0.86, 4.93). Significant associations were not observed in either cohort among women with prenatal symptoms only or women with prenatal and postnatal symptoms. CONCLUSIONS: Male fetal sex was associated with the onset of depressive symptoms during the postnatal period.
BACKGROUND: Fetal sex is known to modify the course and complications of pregnancy, with recent evidence of sex-differential fetal influences on the maternal immune and endocrine systems. In turn, heightened inflammation and surges in reproductive hormone levels associated with pregnancy and parturition have been linked with the development of perinatal depression. Here, we examined whether there is an association between fetal sex and maternal depression assessed during the prenatal and postnatal periods. METHODS: The study included two multi-ethnic, prospective pregnancy cohorts that enrolled women from prenatal clinics in the Northeastern United States between 2001 and 2018. Maternal depressive symptoms were measured during the prenatal and postnatal periods using the Edinburgh Postpartum Depression Scale (EPDS), and newborn sex was reported by the mother following delivery. We used logistic regression to examine associations between fetal sex and maternal depressive symptoms (EPDS > 10) during the prenatal period only, postnatal period only, or both periods versus no depressive symptoms during either period. We considered both unadjusted models and models adjusted for a core set of sociodemographic and lifestyle variables. RESULTS: In adjusted models using PRISM data (N = 528), women pregnant with a male versus female fetus had significantly greater odds of depressive symptoms during the postnatal period compared to women without depressive symptoms during either period (odds ratio [OR] = 5.24, 95% confidence interval [CI] = 1.93, 14.21). The direction of results was consistent in the ACCESS cohort, although the findings did not reach statistical significance (OR = 2.05, 95% CI = 0.86, 4.93). Significant associations were not observed in either cohort among women with prenatal symptoms only or women with prenatal and postnatal symptoms. CONCLUSIONS: Male fetal sex was associated with the onset of depressive symptoms during the postnatal period.
Entities:
Keywords:
Depression; Fetus; Postnatal; Postpartum; Pregnancy; Sex
Authors: Miguel A Diego; Tiffany Field; Maria Hernandez-Reif; Saul Schanberg; Cynthia Kuhn; Victor Hugo Gonzalez-Quintero Journal: Early Hum Dev Date: 2008-08-23 Impact factor: 2.079
Authors: Alan Stein; Rebecca M Pearson; Sherryl H Goodman; Elizabeth Rapa; Atif Rahman; Meaghan McCallum; Louise M Howard; Carmine M Pariante Journal: Lancet Date: 2014-11-14 Impact factor: 79.321
Authors: Michelle Z L Kee; Ai Ling Teh; Andrew Clappison; Irina Pokhvisneva; Julie L MacIssac; David T S Lin; Katia E Ramadori; Birit F P Broekman; Helen Chen; Mary Lourdes Daniel; Neerja Karnani; Michael S Kobor; Peter D Gluckman; Yap Seng Chong; Jonathan Y Huang; Michael J Meaney Journal: iScience Date: 2022-08-04